Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Smoking Rates and Number of Cigarettes Smoked per Day in Schizophrenia: A Large Cohort Meta-Analysis in a Japanese Population
Kazutaka Ohi, Takamitsu Shimada, Aki Kuwata, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 1, pp. 19-27
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Nicotine’s effect on cognition, a friend or foe?
Qian Wang, Weihong Du, Hao Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 124, pp. 110723-110723
Closed Access | Times Cited: 28
Smoking in schizophrenia
Marina Šagud, Alma Mihaljević Peleš, Nela Pivac
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 5, pp. 402-408
Open Access | Times Cited: 75
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
Paula Soria‐Chacartegui, Gonzalo Villapalos‐García, Pablo Zubiaur, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Physical, Psychiatric, and Social Comorbidities of Individuals with Schizophrenia Living in the Community in Japan
Masaaki Matsunaga, Yuanying Li, Yupeng He, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4336-4336
Open Access | Times Cited: 11
Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants
Kazutaka Ohi, Daisuke Nishizawa, Takamitsu Shimada, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 3, pp. 157-164
Open Access | Times Cited: 29
Nucleus Accumbens Proteome Disbalance in an Adolescent Mouse Model of Schizophrenia and Nicotine Misuse Comorbidity
Thainá P. Souza, Andrés Rodríguez-Vega, Ana Carolina Dutra-Tavares, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 901-901
Open Access
Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls
Kazutaka Ohi, Miori Ishibashi, Kaai Torii, et al.
Journal of Psychiatry and Neuroscience (2022) Vol. 47, Iss. 2, pp. E77-E85
Open Access | Times Cited: 16
Intelligence decline between present and premorbid IQ in schizophrenia: Schizophrenia Non-Affected Relative Project (SNARP)
Kazutaka Ohi, Takamitsu Shimada, Yuzuru Kataoka, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 5, pp. 653-661
Closed Access | Times Cited: 22
Differences in Executive Function Among Patients With Schizophrenia, Their Unaffected First-Degree Relatives, and Healthy Participants
Yuzuru Kataoka, Takamitsu Shimada, Y. Koide, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 11, pp. 731-737
Open Access | Times Cited: 17
Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia
Kazutaka Ohi, Daisuke Nishizawa, Yukimasa Muto, et al.
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 17
Alterations in hippocampal subfield volumes among schizophrenia patients, their first-degree relatives and healthy subjects
Kazutaka Ohi, Kiyotaka Nemoto, Yuzuru Kataoka, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110291-110291
Closed Access | Times Cited: 14
Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia
Kazutaka Ohi, Kentaro Takai, Shunsuke Sugiyama, et al.
CNS Spectrums (2021), pp. 1-7
Closed Access | Times Cited: 14
Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia
Shuochi Wei, Dongmei Wang, Gao‐Xia Wei, et al.
Psychopharmacology (2020) Vol. 237, Iss. 11, pp. 3409-3416
Closed Access | Times Cited: 14
Cigarette smoking and schizophrenia: Mendelian randomisation study
Jianhua Chen, Ruirui Chen, Siying Xiang, et al.
The British Journal of Psychiatry (2020) Vol. 218, Iss. 2, pp. 98-103
Closed Access | Times Cited: 13
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis
Alessandro Miola, Michele Fornaro, Fabio Sambataro, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
Demographic, biochemical, clinical, and cognitive symptom differences between smokers and non-smokers in Chinese older male patients with chronic schizophrenia
Wei Li, Ling Yue, Shifu Xiao
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 1
Nicotine’s Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters
Ana Carolina Dutra-Tavares, Luciana Araújo Couto, Thainá P. Souza, et al.
Brain Sciences (2024) Vol. 14, Iss. 9, pp. 855-855
Open Access | Times Cited: 1
Olfactory identification ability among schizophrenia patients, their first-degree relatives and healthy subjects
Senichi Fukuda, Kazutaka Ohi, Daisuke Fujikane, et al.
Australian & New Zealand Journal of Psychiatry (2023) Vol. 57, Iss. 10, pp. 1367-1374
Closed Access | Times Cited: 3
Prevalence and determinants of tobacco use amongst South African adults with mental illness in the Eastern Cape
Linda K. Tindimwebwa, Anthony Idowu Ajayi, Oladele Vincent Adeniyi
South African Journal of Psychiatry (2021) Vol. 27
Open Access | Times Cited: 7
Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model
Ana Carolina Dutra-Tavares, Alex C. Manhães, Keila A. Semeão, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257986-e0257986
Open Access | Times Cited: 7
Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan
Yuji Higuchi, Masaki Fujiwara, Naoki Nakaya, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer
Yi Chai, Rachel Yui Ki Chu, Yuqi Hu, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice
Andrés Rodríguez-Vega, Ana Carolina Dutra-Tavares, Thainá P. Souza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14634-14634
Open Access | Times Cited: 2
Effects of genome-wide neuroticism-associated variants on five-factor model personality traits in schizophrenia
Kazutaka Ohi, Shunsuke Sugiyama, Midori Soda, et al.
Neuroscience Research (2021) Vol. 172, pp. 87-91
Closed Access | Times Cited: 4
Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia
Shuochi Wei, Dongmei Wang, Huixia Zhou, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 7, pp. 1325-1333
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top